2-(hydroxymethyl)-N-methylbenzamide, 95.0%, 500mg

3a,4,5,9b-Tetrahydro-3 H -cyclopenta[ c ]quinoline-4-carboxylic acid, 95.0%, 1g

1-Hexadecanol, 95.0%, 500g

3-(Difluoromethyl)cyclobutanecarboxylic acid, 98%, 500mg

N-methyl-N-(4-piperidin-1-ylbenzyl)amine, 250mg

3-Hydroxy-2,2-dimethylpropanal, 95.0%, 25g

[2-Chloro-5-methyl-4-(methylsulfonyl)phenyl]hydrazine, 95.0%, 5g

Cabazitaxel>98.0%(HPLC)25mg

2,5,8-Tribromobenzo[1,2-b:3,4-b':5,6-b"]trithiophene, 97%, 100mg

N-[2-(1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)ethyl]propanamide, 98%, 100mg

2-oxabicyclo[3.1.0]hexane-6-carboxylic acid, 100mg

2-AMINO-1-(3-(TRIFLUOROMETHYL)PHENYL)ETHANONE HCL, 95.0%, 250mg

GC-Kapillarsäule ROTI®Cap-1701, L 25 m, Ø-Innen 0,32 mm, Filmd. 1,00 µm, 1 Stück